De-escalation strategy

DRUG3 trials

Sponsors

Dong-A University, Peking University, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute

Conditions

Acute Myocardial InfarctionBiliary Tract Cancer (BTC)Castration Sensitive Prostate CancerMetastatic Prostate Cancer

Phase 2

A Study Testing if Patients With Advanced Prostate Cancer Who Are Responding Well to Combination Treatment Can Safely Reduce Their Medication to a Single Hormone Therapy, Compared to Continuing Their Current Drugs

Not yet recruitingNCT07838753

Kokilaben Dhirubhai Ambani Hospital and Medical Research InstituteCastration Sensitive Prostate Cancer, Metastatic Prostate Cancer

Start: 2026-09-01End: 2031-09-01Target: 170Updated: 2026-10-07

Phase 4

Ticagrelor De-escalation Strategy in AMI Patients

RecruitingNCT04755387

Dong-A UniversityAcute Myocardial Infarction

Start: 2023-03-27End: 2028-01-31Target: 2312Updated: 2025-10-01

Unknown Phase

HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer

RecruitingNCT07466238

Peking UniversityBiliary Tract Cancer (BTC)

Start: 2026-03-31End: 2029-03-31Target: 40Updated: 2026-05-08